鼻咽癌的免疫治疗研究进展  

Research progress in immunotherapy of nasopharyngeal carcinoma

作　　者：杨开炎 韦永昌[2] 杨秋云(综述) 唐凤珠(审校)[3] YANG Kaiyan;WEI Yongchang;YANG Qiuyun;TANG Fengzhu(Ruikang Clinical Faculty of Guangxi University of Chinese Medicine,Nanning 530000,China;Department of Otorhinolaryngology,Head and Neck Surgery,People′s Hospital of Guangxi Baise;Department of Otorhinolaryngology Head and Neck Surgery,People′s Hospital of Guangxi Zhuang Autonomous Region)

机构地区：[1]广西中医药大学瑞康临床医学院,南宁530000 [2]广西百色市人民医院耳鼻咽喉头颈外科 [3]广西壮族自治区人民医院耳鼻咽喉头颈外科

出　　处：《实用肿瘤学杂志》2021年第6期542-546,共5页Practical Oncology Journal

基　　金：百色市科技计划项目(编号:百科计20161501)。

摘　　要：鼻咽癌是中国南方地区发病率较高的恶性肿瘤,鼻咽癌的治疗目前以同步放化疗为主要治疗方式,早期鼻咽癌的预后较好,而晚期鼻咽癌的预后较差。免疫治疗作为一种治疗恶性肿瘤的新方法,在临床上应用越来越广泛,并在一些恶性肿瘤的治疗上取得较好效果,成为目前临床研究热点。本文对免疫治疗应用在鼻咽癌方面的研究进行综述,以发现存在的问题和新的研究方向。Nasopharyngeal carcinoma is a malignant tumor with a high incidence in southern China.The treatment of nasopharyngeal carcinoma currently uses concurrent radiotherapy and chemotherapy as the main treatment.The prognosis of early nasopharyngeal carcinoma is better,while the prognosis of advanced nasopharyngeal carcinoma is poor.As a new method of treating malignant tumors,immunotherapy is more and more widely used clinically.It has achieved good results in the treatment for some malignant tumors,and has become a current clinical research hotspot.This article reviews the application of immunotherapy in nasopharyngeal carcinoma in order to discover existing problems and new research directions.

关 键 词：鼻咽癌 免疫疗法 细胞免疫治疗 单克隆抗体 肿瘤疫苗 

分 类 号：R739.6[医药卫生—肿瘤]